Survival Benefit With Capecitabine Maintenance in Metastatic CRC Survival Benefit With Capecitabine Maintenance in Metastatic CRC

A new analysis reveals a significant reduction in the risk of death with capecitabine maintenance vs active monitoring. The study was published as a preprint and has not yet been peer reviewed.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news